New tests for cystic fibrosis

Paediatric Respiratory Reviews

Volumn 7, Issue SUPPL. 1, 2006, Pages

  Davies, Jane C ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

CFTR; cystic fibrosis; diagnosis; genetic analysis; ion transport; modifies gene; polymorphism; potential difference

Indexed keywords

ELASTASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSIN;

CLINICAL FEATURE; CYSTIC FIBROSIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FECES ANALYSIS; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; IMMUNOREACTIVITY; MUTATIONAL ANALYSIS; NEWBORN SCREENING; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SWEAT TEST;

EID: 33745220966     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2006.04.220     Document Type: Review

References (5)

1. L.R. Choo-Kang P.L. Zeitlin Type I, II, III, IV, and V cystic fibrosis transmembrane conductance regulator defects and opportunities for therapy Curr Opin Pulm Med 6 2000 521 529
2. H.J. Lai Y. Cheng P.M. Farrell The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: evidence from the United States Cystic Fibrosis Foundation registry data J Pediatr 147 2005 S57 S63
3. J.C. Davies U. Griesenbach E. Alton Modifier genes in cystic fibrosis Pediatr Pulmonol 39 2005 383 391
4. P.G. Middleton D.M. Geddes E.W. Alton Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium Eur Respir J 7 1994 2050 2056
5. T.A. Standaert Standardized procedure for measurement of nasal potential difference: an outcome measure in multicenter cystic fibrosis clinical trials Pediatr Pulmonol 37 2004 385 392